Proteomic analysis of ubiquitin-like posttranslational modifications induced by the adenovirus E4-ORF3 protein

Journal of Virology

Volumn 89, Issue 3, 2015, Pages 1744-1755

  Sohn, Sook Young ^a   Bridges, Rebecca G ^a   Hearing, Patrick ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

E4 ORF3 PROTEIN; MRE11 PROTEIN; NEDD8 PROTEIN; NIBRIN; PROTEOME; SUMO 3 PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; SUMO3 PROTEIN, HUMAN; UBIQUITIN; VIRAL PROTEIN;

ARTICLE; CONJUGATION; CONTROLLED STUDY; IMMUNOPRECIPITATION; MASS SPECTROMETRY; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; SUMOYLATION; UBIQUITINATION; HOST PATHOGEN INTERACTION; HUMAN; HUMAN ADENOVIRUS C; METABOLISM; PHYSIOLOGY;

ADENOVIRIDAE; HUMAN ADENOVIRUS;

ADENOVIRUS E4 PROTEINS; ADENOVIRUSES, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNOPRECIPITATION; MASS SPECTROMETRY; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOME; UBIQUITINS;

EID: 84921531818     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02892-14     Document Type: Article

References (62)

1. Weitzman MD, Lilley CE, Chaurushiya MS. 2010. Genomes in conflict: maintaining genome integrity during virus infection. Annu Rev Microbiol 64:61-81. http://dx.doi.org/10.1146/annurev.micro.112408.134016.
2. Weitzman MD, Ornelles DA. 2005. Inactivating intracellular antiviral responses during adenovirus infection. Oncogene 24:7686-7696. http://dx.doi.org/10.1038/sj.onc.1209063.
3. Karen KA, Hearing P. 2011. Adenovirus core protein VII protects the viral genome from a DNA damage response at early times after infection. J Virol 85:4135-4142. http://dx.doi.org/10.1128/JVI.02540-10.
4. Harada JN, Shevchenko A, Pallas DC, Berk AJ. 2002. Analysis of the adenovirus E1B-55K-anchored proteome reveals its link to ubiquitination machinery. J Virol 76:9194-9206. http://dx.doi.org/10.1128/JVI.76.18.9194-9206.2002.
5. Querido E, Blanchette P, Yan Q, Kamura T, Morrison M, Boivin D, Kaelin WG, Conaway RC, Conaway JW, Branton PE. 2001. Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complex. Genes Dev 15:3104-3117. http://dx.doi.org/10.1101/gad.926401.
6. Stracker TH, Carson CT, Weitzman MD. 2002. Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex. Nature 418:348-352. http://dx.doi.org/10.1038/nature00863.
7. Doucas V, Ishov AM, Romo A, Juguilon H, Weitzman MD, Evans RM, Maul GG. 1996. Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure. Genes Dev 10:196-207. http://dx.doi.org/10.1101/gad.10.2.196.
8. Evans JD, Hearing P. 2005. Relocalization of the Mre11-Rad50-Nbs1 complex by the adenovirus E4 ORF3 protein is required for viral replication. J Virol 79:6207-6215. http://dx.doi.org/10.1128/JVI.79.10.6207-6215.2005.
9. Ullman AJ, Hearing P. 2008. Cellular proteins PML and Daxx mediate an innate antiviral defense antagonized by the adenovirus E4 ORF3 protein. J Virol 82:7325-7335. http://dx.doi.org/10.1128/JVI.00723-08.
10. Ullman AJ, Reich NC, Hearing P. 2007. Adenovirus E4 ORF3 protein inhibits the interferon-mediated antiviral response. J Virol 81:4744-4752. http://dx.doi.org/10.1128/JVI.02385-06.
11. Sohn SY, Hearing P. 2012. Adenovirus regulates sumoylation of Mre11-Rad50-Nbs1 components through a paralog-specific mechanism. J Virol 86:9656-9665. http://dx.doi.org/10.1128/JVI.01273-12.
12. Citro S, Chiocca S. 2013. Sumo paralogs: redundancy and divergencies. Front Biosci 5:544-553. https://www.bioscience.org/2013/v5s/af/388/fulltext.htm.
13. Hay RT. 2013. Decoding the SUMO signal. Biochem Soc Trans 41:463-473. http://dx.doi.org/10.1042/BST20130015.
14. Becker J, Barysch SV, Karaca S, Dittner C, Hsiao HH, Berriel Diaz M, Herzig S, Urlaub H, Melchior F. 2013. Detecting endogenous SUMO targets in mammalian cells and tissues. Nat Struct Mol Biol 20:525-531. http://dx.doi.org/10.1038/nsmb.2526.
15. Blomster HA, Hietakangas V, Wu J, Kouvonen P, Hautaniemi S, Sistonen L. 2009. Novel proteomics strategy brings insight into the prevalence of SUMO-2 target sites. Mol Cell Proteomics 8:1382-1390. http://dx.doi.org/10.1074/mcp.M800551-MCP200.
16. Blomster HA, Imanishi SY, Siimes J, Kastu J, Morrice NA, Eriksson JE, Sistonen L. 2010. In vivo identification of sumoylation sites by a signature tag and cysteine-targeted affinity purification. J Biol Chem 285:19324-19329. http://dx.doi.org/10.1074/jbc.M110.106955.
17. Bruderer R, Tatham MH, Plechanovova A, Matic I, Garg AK, Hay RT. 2011. Purification and identification of endogenous polySUMO conjugates. EMBO Rep 12:142-148. http://dx.doi.org/10.1038/embor.2010.206.
18. Da Silva-Ferrada E, Xolalpa W, Lang V, Aillet F, Martin-Ruiz I, de la Cruz-Herrera CF, Lopitz-Otsoa F, Carracedo A, Goldenberg SJ, Rivas C, England P, Rodriguez MS. 2013. Analysis of SUMOylated proteins using SUMO-traps. Sci Rep 3:1690. http://dx.doi.org/10.1038/srep01690.
19. Galisson F, Mahrouche L, Courcelles M, Bonneil E, Meloche S, Chelbi-Alix MK, Thibault P. 2011. A novel proteomics approach to identify SUMOylated proteins and their modification sites in human cells. Mol Cell Proteomics 10:M110.004796. http://dx.doi.org/10.1074/mcp.M110.004796.
20. Tatham MH, Rodriguez MS, Xirodimas DP, Hay RT. 2009. Detection of protein SUMOylation in vivo. Nat Protoc 4:1363-1371. http://dx.doi.org/10.1038/nprot.2009.128.
21. Knuesel M, Cheung HT, Hamady M, Barthel KK, Liu X. 2005. A method of mapping protein sumoylation sites by mass spectrometry using a modified small ubiquitin-like modifier 1 (SUMO-1) and a computational program. Mol Cell Proteomics 4:1626-1636. http://dx.doi.org/10.1074/mcp.T500011-MCP200.
22. Lee KA, Hammerle LP, Andrews PS, Stokes MP, Mustelin T, Silva JC, Black RA, Doedens JR. 2011. Ubiquitin ligase substrate identification through quantitative proteomics at both the protein and peptide levels. J Biol Chem 286:41530-41538. http://dx.doi.org/10.1074/jbc.M111.248856.
23. Nevels M, Täuber B, Kremmer E, Spruss T, Wolf H, Dobner T. 1999. Transforming potential of the adenovirus type 5 E4orf3 protein. J Virol 73:1591-1600.
24. Vink EI, Yondola MA, Wu K, Hearing P. 2012. Adenovirus E4-ORF3-dependent relocalization of TIF1α and TIF1γ relies on access to the coiled-coil motif. Virology 422:317-325. http://dx.doi.org/10.1016/j.virol.2011.10.033.
25. Olsen JV, de Godoy LM, Li G, Macek B, Mortensen P, Pesch R, Makarov A, Lange O, Horning S, Mann M. 2005. Parts per million mass accuracy on an Orbitrap mass spectrometer via lock mass injection into a C-trap. Mol Cell Proteomics 4:2010-2021. http://dx.doi.org/10.1074/mcp.T500030-MCP200.
26. Lundgren DH, Martinez H, Wright ME, Han DK. 2009. Protein identification using Sorcerer 2 and SEQUEST. Curr Protoc Bioinformatics Chapter 13:Unit 13.3. http://dx.doi.org/10.1002/0471250953.bi1303s28.
27. Guo A, Gu H, Zhou J, Mulhern D, Wang Y, Lee KA, Yang V, Aguiar M, Kornhauser J, Jia X, Ren J, Beausoleil SA, Silva JC, Vemulapalli V, Bedford MT, Comb MJ. 2014. Immunoaffinity enrichment and mass spectrometry analysis of protein methylation. Mol Cell Proteomics 13:372-387. http://dx.doi.org/10.1074/mcp.O113.027870.
28. Stokes MP, Farnsworth CL, Moritz A, Silva JC, Jia X, Lee KA, Guo A, Polakiewicz RD, Comb MJ. 2012. PTMScan direct: identification and quantification of peptides from critical signaling proteins by immunoaffinity enrichment coupled with LC-MS/MS. Mol Cell Proteomics 11:187-201. http://dx.doi.org/10.1074/mcp.M111.015883.
29. Wolfrum N, Greber UF. 2013. Adenovirus signalling in entry. Cell Microbiol 15:53-62. http://dx.doi.org/10.1111/cmi.12053.
30. Blanchette P, Branton PE. 2009. Manipulation of the ubiquitinproteasome pathway by small DNA tumor viruses. Virology 384:317-323. http://dx.doi.org/10.1016/j.virol.2008.10.005.
31. Wimmer P, Blanchette P, Schreiner S, Ching W, Groitl P, Berscheminski J, Branton PE, Will H, Dobner T. 2013. Cross-talk between phosphorylation and SUMOylation regulates transforming activities of an adenoviral oncoprotein. Oncogene 32:1626-1637. http://dx.doi.org/10.1038/onc.2012.187.
32. Zhao C, Collins MN, Hsiang TY, Krug RM. 2013. Interferon-induced ISG15 pathway: an ongoing virus-host battle. Trends Microbiol 21:181-186. http://dx.doi.org/10.1016/j.tim.2013.01.005.
33. Baker A, Rohleder KJ, Hanakahi LA, Ketner G. 2007. Adenovirus E4 34k and E1b 55k oncoproteins target host DNA ligase IV for proteasomal degradation. J Virol 81:7034-7040. http://dx.doi.org/10.1128/JVI.00029-07.
34. Blackford AN, Patel RN, Forrester NA, Theil K, Groitl P, Stewart GS, Taylor AM, Morgan IM, Dobner T, Grand RJ, Turnell AS. 2010. Adenovirus 12 E4orf6 inhibits ATR activation by promoting TOPBP1 degradation. Proc Natl Acad Sci USA 107:12251-12256. http://dx.doi.org/10.1073/pnas.0914605107.
35. Dallaire F, Blanchette P, Groitl P, Dobner T, Branton PE. 2009. Identification of integrin α3 as a new substrate of the adenovirus E4orf6/E1B 55-kilodalton E3 ubiquitin ligase complex. J Virol 83:5329-5338. http://dx.doi.org/10.1128/JVI.00089-09.
36. Gupta A, Jha S, Engel DA, Ornelles DA, Dutta A. 2013. Tip60 degradation by adenovirus relieves transcriptional repression of viral transcriptional activator EIA. Oncogene 32:5017-5025. http://dx.doi.org/10.1038/onc.2012.534.
37. Orazio NI, Naeger CM, Karlseder J, Weitzman MD. 2011. The adenovirus E1b55K/E4orf6 complex induces degradation of the Bloom helicase during infection. J Virol 85:1887-1892. http://dx.doi.org/10.1128/JVI.02134-10.
38. Schreiner S, Wimmer P, Sirma H, Everett RD, Blanchette P, Groitl P, Dobner T. 2010. Proteasome-dependent degradation of Daxx by the viral E1B-55K protein in human adenovirus-infected cells. J Virol 84:7029-7038. http://dx.doi.org/10.1128/JVI.00074-10.
39. Tammsalu T, Matic I, Jaffray EG, Ibrahim AF, Tatham MH, Hay RT. 2014. Proteome-wide identification of SUMO2 modification sites. Sci Signal 7:rs2. http://dx.doi.org/10.1126/scisignal.2005146.
40. Cremona CA, Sarangi P, Yang Y, Hang LE, Rahman S, Zhao X. 2012. Extensive DNA damage-induced sumoylation contributes to replication and repair and acts in addition to the mec1 checkpoint. Mol Cell 45:422-432. http://dx.doi.org/10.1016/j.molcel.2011.11.028.
41. Impens F, Radoshevich L, Cossart P, Ribet D. 2014. Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli. Proc Natl Acad Sci U S A 111:12432-12437. http://dx.doi.org/10.1073/pnas.1413825111.
42. Jackson SP, Durocher D. 2013. Regulation of DNA damage responses by ubiquitin and SUMO. Mol Cell 49:795-807. http://dx.doi.org/10.1016/j.molcel.2013.01.017.
43. Fox JT, Lee KY, Myung K. 2011. Dynamic regulation of PCNA ubiquitylation/deubiquitylation. FEBS Lett 585:2780-2785. http://dx.doi.org/10.1016/j.febslet.2011.05.053.
44. Galanty Y, Belotserkovskaya R, Coates J, Polo S, Miller KM, Jackson SP. 2009. MammalianSUMOE3-ligases PIAS1 and PIAS4 promote responses to DNA double-strand breaks. Nature 462:935-939. http://dx.doi.org/10.1038/nature08657.
45. Morris JR, Boutell C, Keppler M, Densham R, Weekes D, Alamshah A, Butler L, Galanty Y, Pangon L, Kiuchi T, Ng T, Solomon E. 2009. The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress. Nature 462:886-890. http://dx.doi.org/10.1038/nature08593.
46. Hoppe A, Beech SJ, Dimmock J, Leppard KN. 2006. Interaction of the adenovirus type 5 E4 Orf3 protein with promyelocytic leukemia protein isoform II is required for ND10 disruption. J Virol 80:3042-3049. http://dx.doi.org/10.1128/JVI.80.6.3042-3049.2006.
47. Yondola MA, Hearing P. 2007. The adenovirus E4 ORF3 protein binds and reorganizes the TRIM family member transcriptional intermediary factor 1 alpha. J Virol 81:4264-4271. http://dx.doi.org/10.1128/JVI.02629-06.
48. Rajsbaum R, Garcia-Sastre A, Versteeg GA. 2014. TRIMmunity: the roles of the TRIM E3-ubiquitin ligase family in innate antiviral immunity. J Mol Biol 426:1265-1284. http://dx.doi.org/10.1016/j.jmb.2013.12.005.
49. Glass M, Everett RD. 2013. Components of promyelocytic leukemia nuclear bodies (ND10) act cooperatively to repress herpesvirus infection. J Virol 87:2174-2185. http://dx.doi.org/10.1128/JVI.02950-12.
50. Shen TH, Lin HK, Scaglioni PP, Yung TM, Pandolfi PP. 2006. The mechanisms of PML-nuclear body formation. Mol Cell 24:331-339. http://dx.doi.org/10.1016/j.molcel.2006.09.013.
51. Maul GG, Negorev D, Bell P, Ishov AM. 2000. Review: properties and assembly mechanisms of ND10, PML bodies, or PODs. J Struct Biol 129:278-287. http://dx.doi.org/10.1006/jsbi.2000.4239.
52. Peng H, Feldman I, Rauscher FJ, III. 2002. Hetero-oligomerization among the TIF family of RBCC/TRIM domain-containing nuclear cofactors: a potential mechanism for regulating the switch between coactivation and corepression. J Mol Biol 320:629-644. http://dx.doi.org/10.1016/S0022-2836(02)00477-1.
53. Kim W, Bennett EJ, Huttlin EL, Guo A, Li J, Possemato A, Sowa ME, Rad R, Rush J, Comb MJ, Harper JW, Gygi SP. 2011. Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell 44:325-340. http://dx.doi.org/10.1016/j.molcel.2011.08.025.
54. Wagner SA, Beli P, Weinert BT, Nielsen ML, Cox J, Mann M, Choudhary C. 2011. A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol Cell Proteomics 10: M111.013284. http://dx.doi.org/10.1074/mcp.M111.013284.
55. Roy AL. 2012. Biochemistry and biology of the inducible multifunctional transcription factor TFII-I: 10 years later. Gene 492:32-41. http://dx.doi.org/10.1016/j.gene.2011.10.030.
56. Tussie-Luna M, Bayarsaihan D, Seto E, Ruddle FH, Roy AL. 2002. Physical and functional interactions of histone deacetylase 3 with TFII-I family proteins and PIASxbeta. Proc Natl Acad Sci USA 99:12807-12812. http://dx.doi.org/10.1073/pnas.192464499.
57. Tussie-Luna MI, Michel B, Hakre S, Roy AL. 2002. The SUMO ubiquitin-protein isopeptide ligase family member Miz1/PIASxbeta/Siz2 is a transcriptional cofactor for TFII-I. J Biol Chem 277:43185-43193. http://dx.doi.org/10.1074/jbc.M207635200.
58. Chu Y, Yang X. 2011. SUMO E3 ligase activity of TRIM proteins. Oncogene 30:1108-1116. http://dx.doi.org/10.1038/onc.2010.462.
59. Ikeuchi Y, Dadakhujaev S, Chandhoke AS, Huynh MA, Oldenborg A, Ikeuchi M, Deng L, Bennett EJ, Harper J W, Bonni A, Bonni S. 2014. TIF1gamma protein regulates epithelial-mesenchymal transition by operating as a small ubiquitin-like modifier (SUMO) E3 ligase for the transcriptional regulator SnoN1. J Biol Chem 289:25067-25078. http://dx.doi.org/10.1074/jbc.M114.575878.
60. Ivanov AV, Peng H, Yurchenko V, Yap KL, Negorev DG, Schultz DC, Psulkowski E, Fredericks WJ, White DE, Maul GG, Sadofsky MJ, Zhou MM, Rauscher FJ, III. 2007. PHD domain-mediated E3 ligase activity directs intramolecular sumoylation of an adjacent bromodomain required for gene silencing. Mol Cell 28:823-837. http://dx.doi.org/10.1016/j.molcel.2007.11.012.
61. Liang Q, Deng H, Li X, Wu X, Tang Q, Chang TH, Peng H, Rauscher FJ, III, Ozato K, Zhu F. 2011. Tripartite motif-containing protein 28 is a small ubiquitin-related modifier E3 ligase and negative regulator of IFN regulatory factor 7. J Immunol 187:4754-4763. http://dx.doi.org/10.4049/jimmunol.1101704.
62. O'Shea JP, Chou MF, Quader SA, Ryan JK, Church GM, Schwartz D. 2013.pLogo: a probabilistic approach to visualizing sequence motifs. Nat Methods 10:1211-1212. http://dx.doi.org/10.1038/nmeth.2646.